Agonist polypeptide of receptor for Zot and Zonulin

Details Agonist polypeptide of receptor for Zot and Zonulin Agonist polypeptide of receptor for Zot and Zonulin

2007-11-13

2007-11-13

Gupta, Anish (Department: 1654)

Chemistry: natural resins or derivatives; peptides or proteins;

Peptides of 3 to 100 amino acid residues

8 to 10 amino acid residues in defined sequence

Reexamination Certificate

active

10891492

ABSTRACT:
Agonist polypeptide of a receptor protein has been identified. The agonist can be used to facilitate drug and antigen absorption. Suitable routes of administration include oral, nasal, transdermal, and intravenous. Pharmaceutical formulations may comprise a therapeutic agent or an immunogenic agent in combination with the agonist polypeptide.

REFERENCES:
patent: 5665389 (1997-09-01), Fasano
patent: 5827534 (1998-10-01), Fasano
patent: 5864014 (1999-01-01), Fasano
patent: 5908825 (1999-06-01), Fasano et al.
patent: 5912323 (1999-06-01), Fasano
patent: 5945510 (1999-08-01), Fasano
patent: 5948629 (1999-09-01), Fasano
patent: 6458925 (2002-10-01), Fasano
patent: 6670448 (2003-12-01), Fasano
patent: 2002/0123047 (2002-09-01), Burnham
patent: WO 01/89551 (2001-11-01), None
patent: WO 03/066859 (2003-08-01), None
patent: WO-03/066859 (2003-08-01), None
Stenton GR “Proteinase-activated receptor (PAR)-1 and -2 agonists induce mediator release from mast cells by pathways distinct from PAR-1 and PAR-2” J Pharmacol Exp Ther. Aug. 2002;302(2):466-74.
Uzzau, S. et al., “Expression ofVibrio choleraezonula occludens toxin and analysis of its subcellular localization,”Microb. Pathog. (Dec. 1999), vol. 27, No. 6, pp. 377-385 (Abstract only).
Salama, N.N. et al., “The effect of DeltaG on the transport and oral absorption of macromolecules,”J. Pharm. Sci.(May 2004), vol. 93, No. 5, pp. 1310-1319 (Abstract only).
Salama, N.N. et al., “Effect of the biologically active fragment of zonula occludens toxin, delta G, on the intestinal paracellular transport and oral absorption of mannitol,”Int. J. Pharm. Sci. (Jan. 2003), vol. 251, No. 1-2, pp. 113-121 (Abstract only).
Ikeda, O. et al., “Expression of proteinase-activated receptor-2 in human pancreatic cancer: a possible relation to cancer invasion and induction of fibrosis,”Int. J. Oncol. (Feb. 2003), vol. 2, pp. 295-300 (Abstract only).
Frungieri, M.B. et al., “Proliferative action of mast-cell tryptase is mediated by PAR2, COX2, prostaglandins, and PPARγ: Possible relevance to human fibrotic disorders,”PNAS(Nov. 12, 2002), vol. 99, No. 23, pp. 15072-15077.
Baudry, B. et al., “Cloning of a Gene (zot) Encoding a New Toxin Produced byVibrio cholerae,” Infection and Immunity(Feb. 1992), vol. 60, No. 2, pp. 428-434.
Di Pierro, M. et al., “Zonula Occludens Toxin Structure-Function Analysis,”J. Bio. Chem. (Jun. 1, 2001), vol. 276, No. 22, pp. 19160-19165.
Fasano, A. et al., “Vibrio choleraeproduces a second enterotoxin, which affects intestinal tight junctions,”Proc. Natl. Acad. Sci USA(Jun. 1991), vol. 88, pp. 5242-5246.
El Asmar, R. et al., “Host-Dependent Zonulin Secretion Causes the Impairment of the Small Intestine Barrier Function After Bacterial Exposure,”Gastroenterology(2002), vol. 123, No. 5, pp. 1607-1615.
Lu, R. et al., “Affinity Purification and Partial Characterization of the Zonulin/Zonula Occludents Toxin (Zot) Receptor from Human Brain,”J. Neurochem. (2000), vol. 74, No. 1, pp. 320-326.
Uzzau, S. et al., “Purification and preliminary characterization of the zonula occludens toxin receptor from human (CaCo2) and murine (IEC6) intestinal cell lines,”FEMS Microbiology Letters(2001), vol. 194, pp. 1-5.
Ikeda, O. et al., “Expression of proteinase-activated receptor-2 in human pancreatic cancer: A possible relation to cancer invasion and induction of fibrosis,”Int. J. Oncol. (2003), vol. 22, pp. 295-300.
W. Wang et al. “Human zonulin, a potential modulator of intestinal tight junctions” Jnl. of Cell Sciences, vol. 113, pp. 4435-4440 (2000).
A. Fasano, “Modulation of Intestinal Permeability: An Innovative Method of Oral Drug Delivery for the Treatment of Inherited Acquired Human Diseases” Molecular Genetics and Metabolism, vol. 64, pp. 12-18 (1998).
PCT International Search Report for PCT/US04/22753.

Affiliated with

Also associated with

Rating

Agonist polypeptide of receptor for Zot and Zonulin does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Agonist polypeptide of receptor for Zot and Zonulin, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Agonist polypeptide of receptor for Zot and Zonulin will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3887484